Silvercrest Asset Management Group LLC Genprex, Inc. Transaction History

Silvercrest Asset Management Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$3.11 - $4.87 $62,200 - $97,400	20,000 Added 55.56%	56,000 $188,000
Q1 2021 May 17, 2021	BUY	$3.66 - $7.67 $58,560 - $122,720	16,000 Added 80.0%	36,000 $155,000
Q4 2020 Feb 16, 2021	BUY	$3.03 - $5.51 $60,599 - $110,200	20,000 New	20,000 $83,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $64.3M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.